A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients [clinicaltrials:NCT00002168]
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients [clinicaltrials:NCT00002168]
Bio2RDF identifier
NCT00002168
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00002168
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... s Epivir (3TC) plus Crixivan.
brief title [clinicaltrials_vocabulary:brief-title]
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
100 patients will be ra ...... will be treated for 48 weeks.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anti-HIV Agents
CD4 Lymphocyte Count
Didanosine
Drug Therapy, Combination
HIV Protease Inhibitors
Lamivudine
Reverse Transcriptase Inhibitors
Viral Load
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2007-10-01T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00002168
official title [clinicaltrials_vocabulary:official-title]
An Open Label, Randomized, Com ...... Number of >= 10,000 Copies/ml
org study id [clinicaltrials_vocabulary:org-study-id]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2007-10-01T00:00:00Z
identifier
clinicaltrials:NCT00002168
title
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
@en
type
label
A Comparison of Two Anti-HIV T ...... s [clinicaltrials:NCT00002168]
@en